サンプル依頼リスト カート
  • English
市場調査レポート
商品コード
1753866

2034年までのハウスダストダニアレルギーの世界市場機会と戦略

House Dust Mite Allergy Global Market Opportunities And Strategies To 2034

出版日
ページ情報
英文 331 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.06円
2034年までのハウスダストダニアレルギーの世界市場機会と戦略
出版日: 2025年06月20日
発行: The Business Research Company
ページ情報: 英文 331 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のハウスダストダニアレルギー市場は、2019年に13億5,410万米ドルと評価され、2024年までCAGR9.00%以上で成長しました。

ヘルスケア支出の増加

実績期間中、ヘルスケア支出の増加は、ハウスダストダニアレルギー市場の成長を支えました。ヘルスケア支出の増加に伴い、官民両部門とも、アレルギーのような慢性的で生命を脅かさない疾患の診断と管理にリソースを割り当てる傾向が強まっています。資金が増えるにつれて、皮膚プリックテストや血清免疫グロブリンEテスト（IgE）などの診断ツールがより広く使用されるようになり、ハウスダストマイト（HDM）のような誘因のより良い特定や、より早期の治療開始につながっています。支出の増加は、アレルギー・免疫学の専門医が都市部と半都市部の両方に進出することも後押ししています。例えば、2024年1月、米国を拠点とする医療政策調査、世論調査、ジャーナリズムの独立情報源であるKFFによる国民医療費勘定（NHEA）によると、米国の医療費は2023年から2024年にかけて5％増加し、4兆9,000億米ドルに達しました。さらに2023年5月、英国の政府機関である国家統計局は、2020年から2021年にかけて英国のヘルスケア支出は名目で9.4％、実質で9.7％増加したとする報告書を発表しました。2021年の英国の総医療費は3,672億5,000万米ドル（2,807億英ポンド）、医薬品費は518億4,000万米ドル（396億英ポンド）、予防医療への支出は2020年から2021年にかけて大幅に増加し、459億3,000万米ドル（351億英ポンド）に達しました。したがって、ヘルスケア支出の増加がダニアレルギー市場の成長を牽引しました。

目次

第1章 エグゼクティブサマリー

  • ハウスダストダニアレルギー-市場の魅力とマクロ経済情勢

第2章 目次

第3章 表一覧

第4章 図一覧

第5章 レポート構成

第6章 市場の特徴

  • 一般的な市場の定義
  • 概要
  • ダニアレルギー市場定義とセグメンテーション
  • 製品タイプ別の市場セグメンテーション
    • タブレット
    • 点鼻薬
    • 注射剤
  • 治療タイプ別の市場セグメンテーション
    • 薬
    • 鼻洗浄
    • その他のタイプ
  • 診断別の市場セグメンテーション
    • 皮膚プリックテスト（SPT）
    • 特異的免疫グロブリンE（IgE）血液検査
    • その他の診断
  • 剤形別の市場セグメンテーション
    • 固体
    • 液体
  • エンドユーザー別の市場セグメンテーション
    • 病院
    • ホームケア
    • 専門クリニック
    • その他のエンドユーザー

第7章 主要な市場動向

  • 小児および青少年のアレルギーケアにおける画期的な進歩
  • アレルギーケアにおける免疫療法の進化を推進する戦略的パートナーシップ
  • ハウスダストダニアレルギーと喘息に対する精密免疫療法の進歩
  • 革新的なAI搭載アレルギー検査が市場力学に革命を起こす
  • 先進免疫療法錠の規制当局の承認

第8章 世界のハウスダストダニアレルギーの増加分析と戦略分析フレームワーク

  • 世界： PESTEL分析
    • 政治的
    • 経済
    • 社会
    • 技術的
    • 環境
    • 法律上
  • エンドユーザー（B2B）の分析
    • 病院
    • ホームケア
    • 専門クリニック
    • その他のエンドユーザー
  • 世界のハウスダストダニアレルギー市場：成長率分析
  • 市場成長実績、2019年～2024年
    • 市場促進要因、2019年～2024年
    • 市場抑制要因、2019年～2024年
  • 市場成長予測、2024年～2029年、2034年
  • 成長予測の貢献要因
    • 量的成長の貢献者
    • 促進要因
    • 抑制要因
  • 世界のハウスダストダニアレルギー総アドレス可能市場（TAM）

第9章 世界のハウスダストダニアレルギー市場：セグメンテーション

  • 世界のハウスダストダニアレルギー市場：製品タイプ別、実績と予測、2019年～2024年、2029年、2034年
  • 世界のハウスダストダニアレルギー市場：治療タイプ別、実績と予測、2019年～2024年、2029年、2034年
  • 世界のハウスダストダニアレルギー市場：診断別、実績と予測、2019年～2024年、2029年、2034年
  • 世界のハウスダストダニアレルギー市場：剤形別、実績と予測、2019年～2024年、2029年、2034年
  • 世界のハウスダストダニアレルギー市場：エンドユーザー別、実績と予測、2019年～2024年、2029年、2034年
  • 世界のハウスダストダニアレルギー市場、錠剤の種類別サブセグメンテーション、実績と予測、2019年～2024年、2029年、2034年
  • 世界のハウスダストダニアレルギー市場、点鼻薬の種類別サブセグメンテーション、実績と予測、2019年～2024年、2029年、2034年
  • 世界のハウスダストダニアレルギー市場、注射剤の種類別サブセグメンテーション、実績と予測、2019年～2024年、2029年、2034年

第10章 ハウスダストダニアレルギー市場：地域・国別分析

  • 世界のハウスダストダニアレルギー市場：地域別、実績と予測、2019年～2024年、2029年、2034年
  • 世界のハウスダストダニアレルギー市場：国別、実績と予測、2019年～2024年、2029年、2034年

第11章 アジア太平洋市場

第12章 西欧市場

第13章 東欧市場

第14章 北米市場

第15章 南米市場

第16章 中東市場

第17章 アフリカ市場

第18章 競合情勢と企業プロファイル

  • 企業プロファイル
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd.
  • Johnson and Johnson
  • Merck & Co. Inc.
  • Bayer AG

第19章 その他の大手企業と革新的企業

  • ALK-Abello A/S
  • Shionogi & Co. Ltd.
  • CSL Limited
  • GlaxoSmithKline Plc
  • Merz Pharma GmbH & Co KGaA
  • Allergopharma GmbH
  • Stallergenes Greer Interntional AG
  • Torii Pharmaceutical Co. Ltd.
  • Circassia Pharmaceuticals Plc
  • Allergy Therapeutics plc.
  • Trio Lifescience Private Limited
  • Worg Pharmaceuticals Co. Ltd.
  • Anergis SA.
  • Ergomed plc
  • Advagene Biopharma Co. Ltd.

第20章 競合ベンチマーキング

第21章 競合ダッシュボード

第22章 主要な合併と買収

  • Stallergenes Greer Acquired HAL Allergy

第23章 最近の動向ハウスダストダニアレルギー市場

第24章 機会と戦略

  • 世界のハウスダストダニアレルギー市場2029年：新たな機会を提供する国
  • 世界のハウスダストダニアレルギー市場2029年：新たな機会を提供するセグメント
  • 世界のハウスダストダニアレルギー市場2029年：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第25章 ハウスダストダニアレルギー市場：結論と提言

  • 結論
  • 提言
    • 製品
    • 場所
    • 価格
    • プロモーション
    • 人々

第26章 付録

目次
Product Code: o&s1680

House dust mite allergy, also known as dust mite allergy or dust allergy, is an allergic reaction triggered by the proteins found in the feces, body parts and secretions of dust mites. Dust mites are microscopic arthropods that thrive in indoor environments, particularly in warm, humid conditions. They are commonly found in bedding, upholstered furniture, carpets, curtains and other soft furnishings where they feed on dead skin cells shed by humans and pets.

The house dust mite allergy market consists of sales, by entities (organizations, sole traders and partnerships), of house dust mite allergy treatment products designed to either reduce exposure to allergens or to treat the symptoms and underlying immune response.

The global house dust mite allergy market was valued at $1,354.10 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 9.00%.

Rising Healthcare Expenditures

During the historic period, the rising healthcare expenditures supported the growth of the house dust mite allergy market. As healthcare spending rises, both public and private sectors increasingly allocate resources toward the diagnosis and management of chronic, non-life-threatening conditions such as allergies. With more funding, diagnostic tools such as skin prick and serum immunoglobulin E tests (IgE) are more widely used, leading to better identification of triggers like house dust mites (HDM) and earlier initiation of treatment. The growth in spending also supports the expansion of allergy and immunology specialists into both urban and semi-urban areas. For instance, in January 2024, according to national health expenditures accounts (NHEA) by KFF, a US-based independent source for health policy research, polling and journalism, health spending in the USA was increased by 5% from 2023 to 2024, reaching $4.9 trillion. Additionally, in May 2023, the UK's Office for National Statistics, a government agency, released a report stating that between 2020 and 2021, healthcare spending in the UK increased by 9.4% nominally and 9.7% practically. The total cost of healthcare in the UK in 2021 was $367.25 billion (£280.7 billion), pharmaceutical costs were $51.84 billion (£39.6 billion) and spending on preventative care increased significantly from 2020 to 2021, reaching $45.93 billion (£35.1 billion). Therefore, the rising healthcare expenditures drove the growth of the house dust mite allergy market.

Strategic Partnerships Driving The Evolution Of Immunotherapy In Allergy Care

Major companies operating in the house dust mite allergy market are adopting strategic partnerships approach to develop advanced solutions. Strategic partnerships help house dust mite allergy companies by combining resources and expertise, enhancing research and development capabilities, expanding market reach and accelerating commercialization, ultimately driving innovation and growth in the house dust mite allergy industry. For instance, in February 2025, ALK, a Denmark-based pharmaceutical company, partnered with Torii Pharmaceutical, a Japan-based pharmaceutical company, that offers house dust mite allergy tablets by granting exclusive rights to develop, market and distribute its allergy immunotherapy tablet for grass pollen allergy in Japan. This agreement builds on their existing collaboration, which already covers cedar pollen and house dust mite (HDM) allergy treatments. Torii Pharmaceutical offers sublingual immunotherapy tablets for HDM allergy under the brand MITICURE, approved for both adults and children. The expanded partnership reinforces Torii's position in the Japanese allergy treatment market and broadens its portfolio of allergen-specific therapies.

The global house dust mite allergy markets are concentrated, with large players operating in the market. The top 10 competitors in the market made up 46.17% of the total market in 2023.

House Dust Mite Allergy Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global house dust mite allergy market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for house dust mite allergy? how does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The house dust mite allergy market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider house dust mite allergy market; and compares it with other markets.

The report covers the following chapters

  • Introduction And Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product type, by treatment type, by diagnosis, by dosage forms and by end users.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Growth Analysis And Strategic Analysis Framework- Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
  • Global Market Size And Growth- Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by product type, by treatment type, by diagnosis, by dosage forms and by end users in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
  • Regional Market Size And Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers And Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Recent Developments- Information on recent developments in the market covered in the report.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for house dust mite allergy providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Product Type: Tablets; Nasal Drops; Injectable
  • 2) By Treatment Type: Medication; Nasal Irrigation; Other Types
  • 3) By Diagnosis: Skin Prick Test (SPT); Specific Immunoglobulin E (IgE) And Blood Test; Other Diagnostics
  • 4) By Dosage Forms: Solid; Liquid
  • 5) By End Users: Hospitals; Homecare; Specialty Clinics; Other End Users
  • Companies Mentioned: Sanofi SA; Teva Pharmaceutical Industries Ltd.; Johnson and Johnson Services Inc.; Merck & Co. Inc.; Bayer AG
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; house dust mite allergy indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 House Dust Mite Allergy - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 House Dust Mite Allergy Market Definition And Segmentations
  • 6.4 Market Segmentation By Product Type
    • 6.4.1 Tablets
    • 6.4.2 Nasal Drops
    • 6.4.3 Injectable
  • 6.5 Market Segmentation By Treatment Type
    • 6.5.1 Medication
    • 6.5.2 Nasal Irrigation
    • 6.5.3 Other Types
  • 6.6 Market Segmentation By Diagnosis
    • 6.6.1 Skin Prick Test (SPT)
    • 6.6.2 Specific Immunoglobulin E (IgE) Blood Test
    • 6.6.3 Other Diagnostics
  • 6.7 Market Segmentation By Dosage Forms
    • 6.7.1 Solid
    • 6.7.2 Liquid
  • 6.8 Market Segmentation By End Users
    • 6.8.1 Hospitals
    • 6.8.2 Homecare
    • 6.8.3 Specialty Clinics
    • 6.8.4 Other End Users

7 Major Market Trends

  • 7.1 Breakthrough In Allergy Care For Children And Adolescents
  • 7.2 Strategic Partnerships Driving The Evolution Of Immunotherapy In Allergy Care
  • 7.3 Advances In Precision Immunotherapy For House Dust Mite Allergy And Asthma
  • 7.4 Innovative AI-Powered Allergy Testing Revolutionizes Market Dynamics
  • 7.5 Regulatory Approvals For Advanced Immunotherapy Tablets

8 Global House Dust Mite Allergy Growth Analysis And Strategic Analysis Framework

  • 8.1 Global: PESTEL Analysis
    • 8.1.1 Political
    • 8.1.2 Economic
    • 8.1.3 Social
    • 8.1.4 Technological
    • 8.1.5 Environmental
    • 8.1.6 Legal
  • 8.2 Analysis Of End User (B2B)
    • 8.2.1 Hospitals
    • 8.2.2 Homecare
    • 8.2.3 Specialty Clinics
    • 8.2.4 Other End Users
  • 8.3 Global House Dust Mite Allergy Market Growth Rate Analysis
  • 8.4 Historic Market Growth, 2019 - 2024, Value ($ Million)
    • 8.4.1 Market Drivers 2019 - 2024
    • 8.4.2 Market Restraints 2019 - 2024
  • 8.5 Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
  • 8.6 Forecast Growth Contributors/Factors
    • 8.6.1 Quantitative Growth Contributors
    • 8.6.2 Drivers
    • 8.6.3 Restraints
  • 8.7 Global House Dust Mite Allergy Total Addressable Market (TAM)

9 Global House Dust Mite Allergy Market Segmentation

  • 9.1 Global House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.2 Global House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.3 Global House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.4 Global House Dust Mite Allergy Market, Segmentation By Dosage Forms, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.5 Global House Dust Mite Allergy Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.6 Global House Dust Mite Allergy Market, Sub-Segmentation Of Tablets, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.7 Global House Dust Mite Allergy Market, Sub-Segmentation Of Nasal Drops, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.8 Global House Dust Mite Allergy Market, Sub-Segmentation Of Injectable, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

10 House Dust Mite Allergy Market, Regional and Country Analysis

  • 10.1 Global House Dust Mite Allergy Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 10.2 Global House Dust Mite Allergy Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Asia-Pacific Market

  • 11.1 Summary
  • 11.2 Market Overview
    • 11.2.1 Region Information
    • 11.2.2 Market Information
    • 11.2.3 Background Information
    • 11.2.4 Government Initiatives
    • 11.2.5 Regulations
    • 11.2.6 Regulatory Bodies
    • 11.2.7 Major Associations
    • 11.2.8 Taxes Levied
    • 11.2.9 Corporate Tax Structure
    • 11.2.10 Investments
    • 11.2.11 Major Companies
  • 11.3 Asia-Pacific House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.4 Asia-Pacific House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.5 Asia-Pacific House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.6 Asia-Pacific House Dust Mite Allergy Market: Country Analysis
  • 11.7 China Market
  • 11.8 Summary
  • 11.9 Market Overview
    • 11.9.1 Country Information
    • 11.9.2 Market Information
    • 11.9.3 Background Information
    • 11.9.4 Government Initiatives
    • 11.9.5 Regulations
    • 11.9.6 Regulatory Bodies
    • 11.9.7 Major Associations
    • 11.9.8 Taxes Levied
    • 11.9.9 Corporate Tax Structure
    • 11.9.10 Investments
    • 11.9.11 Major Companies
  • 11.10 China House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.11 China House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.12 China House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.13 India Market
  • 11.14 India House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.15 India House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.16 India House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.17 Japan Market
  • 11.18 Summary
  • 11.19 Market Overview
    • 11.19.1 Country Information
    • 11.19.2 Market Information
    • 11.19.3 Background Information
    • 11.19.4 Government Initiatives
    • 11.19.5 Regulations
    • 11.19.6 Regulatory Bodies
    • 11.19.7 Major Associations
    • 11.19.8 Taxes Levied
    • 11.19.9 Corporate Tax Structure
    • 11.19.10 Investments
    • 11.19.11 Major Companies
  • 11.20 Japan House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.21 Japan House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.22 Japan House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.23 South Korea Market
  • 11.24 Summary
  • 11.25 Market Overview
    • 11.25.1 Country Information
    • 11.25.2 Market Information
    • 11.25.3 Background Information
    • 11.25.4 Regulations
    • 11.25.5 Regulatory Bodies
    • 11.25.6 Major Associations
    • 11.25.7 Taxes Levied
    • 11.25.8 Corporate Tax Structure
    • 11.25.9 Major Companies
  • 11.26 South Korea House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.27 South Korea House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.28 South Korea House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.29 Australia Market
  • 11.30 Australia House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.31 Australia House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.32 Australia House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.33 Indonesia Market
  • 11.34 Indonesia House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.35 Indonesia House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.36 Indonesia House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Western Europe Market

  • 12.1 Summary
  • 12.2 Market Overview
    • 12.2.1 Region Information
    • 12.2.2 Market Information
    • 12.2.3 Background Information
    • 12.2.4 Government Initiatives
    • 12.2.5 Regulations
    • 12.2.6 Regulatory Bodies
    • 12.2.7 Major Associations
    • 12.2.8 Taxes Levied
    • 12.2.9 Corporate tax structure
    • 12.2.10 Investments
    • 12.2.11 Major Companies
  • 12.3 Western Europe House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.4 Western Europe House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.5 Western Europe House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.6 Western Europe House Dust Mite Allergy Market: Country Analysis
  • 12.7 UK Market
  • 12.8 UK House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.9 UK House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.10 UK House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.11 Germany Market
  • 12.12 Germany House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.13 Germany House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.14 Germany House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.15 France Market
  • 12.16 France House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.17 France House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.18 France House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.19 Italy Market
  • 12.20 Italy House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.21 Italy House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.22 Italy House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.23 Spain Market
  • 12.24 Spain House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.25 Spain House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.26 Spain House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Eastern Europe Market

  • 13.1 Summary
  • 13.2 Market Overview
    • 13.2.1 Region Information
    • 13.2.2 Market Information
    • 13.2.3 Background Information
    • 13.2.4 Government Initiatives
    • 13.2.5 Regulations
    • 13.2.6 Regulatory Bodies
    • 13.2.7 Major Associations
    • 13.2.8 Taxes Levied
    • 13.2.9 Corporate Tax Structure
    • 13.2.10 Major companies
  • 13.3 Eastern Europe House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.4 Eastern Europe House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.5 Eastern Europe House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.6 Russia Market
  • 13.7 Russia House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.8 Russia House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.9 Russia House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 North America Market

  • 14.1 Summary
  • 14.2 Market Overview
    • 14.2.1 Region Information
    • 14.2.2 Market Information
    • 14.2.3 Background Information
    • 14.2.4 Government Initiatives
    • 14.2.5 Regulations
    • 14.2.6 Regulatory Bodies
    • 14.2.7 Major Associations
    • 14.2.8 Taxes Levied
    • 14.2.9 Corporate Tax Structure
    • 14.2.10 Investments
    • 14.2.11 Major Companies
  • 14.3 North America House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.4 North America House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.5 North America House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.6 North America House Dust Mite Allergy Market: Country Analysis
  • 14.7 USA Market
  • 14.8 Summary
  • 14.9 Market Overview
    • 14.9.1 Country Information
    • 14.9.2 Market Information
    • 14.9.3 Background Information
    • 14.9.4 Government Initiatives
    • 14.9.5 Regulations
    • 14.9.6 Regulatory Bodies
    • 14.9.7 Major Associations
    • 14.9.8 Taxes Levied
    • 14.9.9 Corporate Tax Structure
    • 14.9.10 Investments
    • 14.9.11 Major Companies
  • 14.10 USA House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.11 USA House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.12 USA House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.13 Canada Market
  • 14.14 Summary
  • 14.15 Market Overview
    • 14.15.1 Country Information
    • 14.15.2 Market Information
    • 14.15.3 Background Information
    • 14.15.4 Government Initiatives
    • 14.15.5 Regulations
    • 14.15.6 Regulatory Bodies
    • 14.15.7 Major Associations
    • 14.15.8 Taxes Levied
    • 14.15.9 Corporate Tax Structure
    • 14.15.10 Major Companies
  • 14.16 Canada House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.17 Canada House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.18 Canada House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 South America Market

  • 15.1 Summary
  • 15.2 Market Overview
    • 15.2.1 Region Information
    • 15.2.2 Market Information
    • 15.2.3 Background Information
    • 15.2.4 Government Initiatives
    • 15.2.5 Regulations
    • 15.2.6 Regulatory Bodies
    • 15.2.7 Major Associations
    • 15.2.8 Taxes Levied
    • 15.2.9 Corporate Tax Structure
    • 15.2.10 Major Companies
  • 15.3 South America House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.4 South America House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.5 South America House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.6 Brazil Market
  • 15.7 Brazil House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.8 Brazil House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.9 Brazil House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 Middle East Market

  • 16.1 Summary
  • 16.2 Market Overview
    • 16.2.1 Region Information
    • 16.2.2 Market Information
    • 16.2.3 Background Information
    • 16.2.4 Government Initiatives
    • 16.2.5 Regulations
    • 16.2.6 Regulatory Bodies
    • 16.2.7 Major Associations
    • 16.2.8 Taxes Levied
    • 16.2.9 Corporate Tax Structure
    • 16.2.10 Major Companies
  • 16.3 Middle East House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.4 Middle East House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.5 Middle East House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Africa Market

  • 17.1 Summary
  • 17.2 Market Overview
    • 17.2.1 Region Information
    • 17.2.2 Market Information
    • 17.2.3 Background Information
    • 17.2.4 Government Initiatives
    • 17.2.5 Regulations
    • 17.2.6 Regulatory Bodies
    • 17.2.7 Major Associations
    • 17.2.8 Taxes Levied
    • 17.2.9 Corporate Tax Structure
    • 17.2.10 Major Companies
  • 17.3 Africa House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.4 Africa House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.5 Africa House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Competitive Landscape And Company Profiles

  • 18.1 Company Profiles
  • 18.2 Sanofi SA
    • 18.2.1 Company Overview
    • 18.2.2 Products And Services
    • 18.2.3 Financial Overview
  • 18.3 Teva Pharmaceutical Industries Ltd.
    • 18.3.1 Company Overview
    • 18.3.2 Products And Services
    • 18.3.3 Financial Overview
  • 18.4 Johnson and Johnson
    • 18.4.1 Company Overview
    • 18.4.2 Products And Services
    • 18.4.3 Financial Overview
  • 18.5 Merck & Co. Inc.
    • 18.5.1 Company Overview
    • 18.5.2 Products And Services
    • 18.5.3 Business Strategy
    • 18.5.4 Financial Overview
  • 18.6 Bayer AG
    • 18.6.1 Company Overview
    • 18.6.2 Products And Services
    • 18.6.3 Financial Overview

19 Other Major And Innovative Companies

  • 19.1 ALK-Abello A/S
    • 19.1.1 Company Overview
    • 19.1.2 Products And Services
  • 19.2 Shionogi & Co. Ltd.
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
  • 19.3 CSL Limited
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
  • 19.4 GlaxoSmithKline Plc
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
  • 19.5 Merz Pharma GmbH & Co KGaA
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
  • 19.6 Allergopharma GmbH
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
  • 19.7 Stallergenes Greer Interntional AG
    • 19.7.1 Company Overview
    • 19.7.2 Products And Services
  • 19.8 Torii Pharmaceutical Co. Ltd.
    • 19.8.1 Company Overview
    • 19.8.2 Products And Services
  • 19.9 Circassia Pharmaceuticals Plc
    • 19.9.1 Company Overview
    • 19.9.2 Products And Services
  • 19.10 Allergy Therapeutics plc.
    • 19.10.1 Company Overview
    • 19.10.2 Products And Services
  • 19.11 Trio Lifescience Private Limited
    • 19.11.1 Company Overview
    • 19.11.2 Products And Services
  • 19.12 Worg Pharmaceuticals Co. Ltd.
    • 19.12.1 Company Overview
    • 19.12.2 Products And Services
  • 19.13 Anergis SA.
    • 19.13.1 Company Overview
    • 19.13.2 Products And Services
  • 19.14 Ergomed plc
    • 19.14.1 Company Overview
    • 19.14.2 Products And Services
  • 19.15 Advagene Biopharma Co. Ltd.
    • 19.15.1 Company Overview
    • 19.15.2 Products And Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 Stallergenes Greer Acquired HAL Allergy

23 Recent Developments In The House Dust Mite Allergy Market

  • 23.1 Revolutionary Treatment For House Dust Mite Allergies Secures NHS Approval

24 Opportunities And Strategies

  • 24.1 Global House Dust Mite Allergy Market In 2029 - Countries Offering Most New Opportunities
  • 24.2 Global House Dust Mite Allergy Market In 2029 - Segments Offering Most New Opportunities
  • 24.3 Global House Dust Mite Allergy Market In 2029 - Growth Strategies
    • 24.3.1 Market Trend Based Strategies
    • 24.3.2 Competitor Strategies

25 House Dust Mite Allergy Market, Conclusions And Recommendations

  • 25.1 Conclusions
  • 25.2 Recommendations
    • 25.2.1 Product
    • 25.2.2 Place
    • 25.2.3 Price
    • 25.2.4 Promotion
    • 25.2.5 People

26 Appendix

  • 26.1 Geographies Covered
  • 26.2 Market Data Sources
  • 26.3 Research Methodology
  • 26.4 Currencies
  • 26.5 The Business Research Company
  • 26.6 Copyright and Disclaimer